Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nam

Showing results (121-130 of 509) with videos related to

Pageof 51
Sort By:
Clinical Pharmacology and Therapeutics|July 3, 1999
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizersJ W Ko, I J Jang, J G Shin, et al.
The Journal of Laryngology and Otology|November 3, 2023
Bilateral Warthin's tumour of the parotid gland: a 16-year retrospective analysis and systematic reviewZohaib Siddiqui, Ahaan Gupta, Ronald H K Nam, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrestGregory J Nason, Khaled Ajib, Guan Hee Tan, et al.
Urology|December 2, 2017
Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV StudyChristopher J D Wallis, Raj Satkunasivam, Refik Saskin, et al.
Journal of Fish Biology|March 14, 2018
Derivation of the clonal-cell lines from Siberian sturgeon (Acipenser baerii) head-kidney cell lines and its applicability to foreign gene expression and virus cultureJ H Ryu, M S Kim, J H Kang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic modelVasundara Venkateswaran, Laurence H Klotz, Meera Ramani, et al.
Clinical Biochemistry|February 7, 2001
Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-upE J Vassilikos, H Yu, J Trachtenberg, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohortAshraf Almatar, Christopher J D Wallis, Sender Herschorn, et al.
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Oncogene|September 30, 2008
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasisH J Kim, Y M Kim, S Lim, et al.
Pageof 51

Showing results (121-130 of 509) with videos related to

Sort By:
Pageof 51
Clinical Pharmacology and Therapeutics|July 3, 1999
Theophylline pharmacokinetics are not altered by lansoprazole in CYP2C19 poor metabolizersJ W Ko, I J Jang, J G Shin, et al.
The Journal of Laryngology and Otology|November 3, 2023
Bilateral Warthin's tumour of the parotid gland: a 16-year retrospective analysis and systematic reviewZohaib Siddiqui, Ahaan Gupta, Ronald H K Nam, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrestGregory J Nason, Khaled Ajib, Guan Hee Tan, et al.
Urology|December 2, 2017
Population-based Analysis of Treatment Toxicity Among Men With Castration-resistant Prostate Cancer: A Phase IV StudyChristopher J D Wallis, Raj Satkunasivam, Refik Saskin, et al.
Journal of Fish Biology|March 14, 2018
Derivation of the clonal-cell lines from Siberian sturgeon (Acipenser baerii) head-kidney cell lines and its applicability to foreign gene expression and virus cultureJ H Ryu, M S Kim, J H Kang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 30, 2009
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic modelVasundara Venkateswaran, Laurence H Klotz, Meera Ramani, et al.
Clinical Biochemistry|February 7, 2001
Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-upE J Vassilikos, H Yu, J Trachtenberg, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohortAshraf Almatar, Christopher J D Wallis, Sender Herschorn, et al.
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Oncogene|September 30, 2008
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasisH J Kim, Y M Kim, S Lim, et al.
Pageof 51